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Medicine and Surgery, Federico II University. PAbstract Background and aim: We aimed to study whether the effect of adolescent adiposity on
adult blood pressure and insulin resistance was mediated by adult adiposity.
Methods and results: Data from the EPITeen cohort at 13, 17 and 21 years was used (n Z 2211).
Sex- and age-speciﬁc body mass index z-scores (BMIz) and waist-to-hip ratio (WHR) were used
as indicators of total and central adiposity, respectively. Systolic blood pressure (SBP), glucose
and insulin were assessed at 21 years and the homeostasis model assessment (HOMA-IR) was
used as a marker of insulin resistance. Path analysis was applied to evaluate direct and indirect
effects of adiposity (13, 17 and 21y) on adult SBP and HOMA-IR, separately for total and central
adiposity and for each outcome. Results are presented as standardized regression coefﬁcients [b
(95%CI)]. The total effect of BMIz at 13 years on SBP at 21 years was 0.211 (0.178; 0.244), totally
mediated by adult BMIz. Total effect of BMIz 13y on HOMA-IR was 0.248 (0.196; 0.299). Although
this effect was mostly mediated by BMIz 21y, an additional direct effect from BMIz 17y was found
[b Z 0.240 (0.315; 0.164)]. Central adiposity was also positively associated with SBP and
HOMA-IR at 21 years, and the effect of adolescent WHR was totally mediated by adult WHR
for both outcomes.
Conclusions: The effect of adolescent adiposity on adult SBP and HOMA-IR was mostly mediated
by adult adiposity. However, for HOMA-IR an additional direct effect from total adiposity at 17
years was found.
ª 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the
Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Feder-
ico II University. Published by Elsevier B.V. All rights reserved.Introduction
The childhood obesity epidemic experienced in last de-
cades, especially in developed countries, is likely to
introduce changes in the pattern and timing of cardio-
vascular disease (CVD), leading to an epidemic of early
onset of CVD risk factors and events [1]. Studies have
shown that changes in adiposity in speciﬁc periods of theSaúde Pública, Rua das Taipas
1 222061821.
p.pt (J. Araújo).
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ublished by Elsevier B.V. All rights reservepaediatric age are inﬂuential for future cardio metabolic
health [2e6]. However, due to the expected tracking of
adiposity from childhood to adulthood [7], there is
increasing interest in decomposing direct effects of early
adiposity on adult outcomes, from those mediated by adult
adiposity. However, most studies measuring the indepen-
dent effects of adiposity in paediatric age on adult out-
comes used standard regression techniques to adjust for
adult adiposity [2e4,8,9], which has been suggested to
cause statistical artefacts and to be controversial regarding
the interpretation of the results [10,11]. For example, in
these models the adjustment for adult adiposity controls
for change in adiposity between measurements, not onlytherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical
d.
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be present [10]. Path analysis has been suggested as a
superior statistical method in comparison to other stan-
dard regressions, since allows the estimation of direct and
indirect effects, producing easily interpretable results [6].
Additionally, it may deal more efﬁciently with collinearity
[6], although some authors argue that it can still be a
problem in life course path analysis [12].
The effects of adiposity on cardiovascular risk factors
may emerge at different periods over the life course
depending on the outcomes studied. Obesity is associated
with both insulin resistance and blood pressure, and these
outcomes may have some shared mechanisms, such as
obesity-induced inﬂammation [13]. However, in youth
insulin resistance or type 2 diabetes are more common
consequences of obesity than hypertension [14,15]. Studies
have also suggested that insulin resistance is implicated in
the subsequent development of hypertension [16]. Still,
the evidence is limited and controversial.
In adults, abdominal fat, particularly visceral fat, has
been clearly associated with the highest risk of CVD dis-
ease [17]. However, in paediatric age studies addressing
changes in adiposity have mainly focused on total
adiposity, remaining the effect of central adiposity under
investigated.
Therefore, we extended the evidence of previous
studies on the effect of adolescent adiposity on adult CVD
risk factors, by studying both total and central adiposity,
and applying life course path analysis. Speciﬁcally, our aim
was to study whether the effect of adolescent adiposity on
adult blood pressure and insulin resistance is mediated by
adult adiposity.
Methods
Study sample
Data was collected as part of the EPITeen study (Epide-
miological Health Investigation of Teenagers in Porto), a
population-based cohort that recruited 13-year-old ado-
lescents born in 1990 and enrolled at public and private
schools of Porto, Portugal, during 2003/2004 [18]. A
second evaluation took place in 2007/2008 and a third
evaluation in 2011e2013, when participants were on
average 17 and 21 years, respectively.
Our study complies with the Declaration of Helsinki and
the Ethic Committee of Hospital S. João and the Ethic
Committee of the Institute of Public Health from the Uni-
versity of Porto approved the research protocol. Written
informed consent was obtained from parents and adoles-
cents in the ﬁrst and second study waves, and from par-
ticipants in the third study wave.
At the recruitment, 2786 eligible participants were
identiﬁed and 2159 (77.5%) agreed to participate. In the
second wave, 1716 participants (79.5%) were re-evaluated,
and a new group of 783 adolescents were evaluated for the
ﬁrst time and integrated the cohort as they moved to the
schools of Porto. In the third study wave, 1764 participants
were re-evaluated. From the entire cohort (n Z 2942),2211 (75%) participants with anthropometric data in, at
least, two study waves were included in this analysis.
Measures
Anthropometrics
Weight and height were obtained with the subject in light
indoor clothes and no shoes. Weight was measured in ki-
lograms, to the nearest tenth, using a digital scale and
height was measure in centimetres, to the nearest tenth,
according to standardized procedures. Waist and hip cir-
cumferences were measured to the nearest 0.1 cm with a
ﬂexible and non-distensible tape, avoiding exertion of
pressure on the tissues and with the subject standing.
Waist circumference was measured midway between the
lower limit of the rib cage and the iliac crest, at the end of
gentle expiration, and hip circumference was measured on
the maximum circumference over the femoral trochanters.
As a measure of total adiposity we used BMI, stan-
dardized according to the sex- and age-speciﬁc growth
reference data for 5e19 years, from the World Health Or-
ganization (WHO) [19]. BMI from the third study wave at
21 years was standardized using the WHO z-scores for 19
years. The waist-to-hip ratio was used as indicator of
central adiposity.
Cardio metabolic parameters at 21 years
An overnight fast intravenous blood sample was taken
from an antecubital vein. Glucose was measured using
conventional methods with an Olympus AU5400 auto-
mated clinical chemistry analyzer (Beckman-Coulter).
Insulin was measured by electro chemiluminescent
immunoassay using a Cobas e411 automated analyzer
(Roche). All determinations took place in the Clinical
Pathology Department of the São João Hospital Center,
Porto. The homeostasis model method (HOMA-IR) was
used as a marker of insulin resistance, based on fasting
glucose and insulin concentrations: HOMA-IR Z insulin
(mU/ml) * glucose (mg/dl)/405 [20].
Blood pressure was measured using an oscillometric
method (OMRON Blood Pressure Monitor, M6 Comfort),
according to standardized procedures. After 10 min of rest,
two blood pressure measurements were taken, separately
by at least ﬁve minutes; a third measure was taken if the
difference between the ﬁrst two was higher than 5 mmHg.
The average of the two closest measurements was used in
the analysis.
Statistical analysis
Data are presented as counts and percentages or mean and
standard deviation (SD), for categorical and quantitative
variables, respectively.
Path analysis was used to evaluate the independent
associations between BMIz and WHR at each age (13, 17
and 21 years) with adult (21 years) SBP or HOMA-IR. Re-
sults are presented as standardized regression coefﬁcients
(b) and 95% conﬁdence intervals (95% CI) to allow direct
comparisons between different exposures and outcomes.
Table 1 Adiposity and cardio metabolic parameters of the study
sample, by sex.
Females Males
Adiposity parameters Mean (SD)
Weight (kg) 13 years 52.6 (9.8) 54.7 (12.0)
17 years 57.3 (9.2) 67.6 (11.4)
21 years 59.0 (10.7) 72.6 (12.4)
BMI (Kg/m2) 13 years 21.0 (3.4) 20.6 (3.6)
17 years 22.0 (3.2) 22.4 (3.4)
21 years 22.6 (4.0) 23.6 (3.7)
BMIz 13 years 0.40 (0.99) 0.47 (1.16)
17 years 0.22 (0.90) 0.29 (1.05)
21 years 0.20 (1.04) 0.31 (1.10)
WC (cm) 13 years 71.5 (7.9) 73.2 (9.3)
17 years 74.2 (7.9) 78.2 (8.6)
21 years 73.8 (9.3) 81.7 (9.3)
WHR 13 years 0.79 (0.06) 0.83 (0.06)
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adolescent adiposity on adult outcomes is mostly medi-
ated by adult adiposity, we started the analysis with a
reduced model as illustrated in Fig. 1. This model included
only the associations between BMIz/WHR at subsequent
ages (13e17 years, and 17e21 years) and the association
between BMIz/WHR at 21 years and the outcome at 21
years (SBP/HOMA-IR). In the second step, we added
additional pathways (one by one), according to the model
modiﬁcation indices. Additional associations were added
only if modiﬁcation index was over 6.63 (c20:990;ð1Þ) to
minimize the probability of type I error. The ﬁnal models
included the direct pathway of BMIz/WHR between 13 and
21 years, and speciﬁcally in the model for BMIz and
HOMA-IR, the direct pathway from BMIz 17y and HOMA-IR
21y.Figure 1 Illustrative example of the reduced path analysis model for
the association between adiposity throughout adolescence and the
outcome in adulthood.
17 years 0.78 (0.06) 0.83 (0.05)
21 years 0.75 (0.06) 0.85 (0.05)
Cardio metabolic parameters 21y Mean (SD)
SBP (mmHg) 102.0 (8.7) 115.9 (10.4)
DBP (mmHg) 68.1 (7.4) 69.6 (7.5)
Glucose (mg/dl) 81.1 (8.2) 85.4 (7.6)
Insulin (mg/dl) 9.5 (4.9) 8.2 (4.7)
HOMA-IR 1.91 (1.06) 1.76 (1.10)
BMIz: body mass index z-score; WHR: waist-to-hip ratio; SBP:
systolic blood pressure; DBP: diastolic blood pressure; HOMA-IR:
insulin resistance index.The goodness-of-ﬁt of the path analysis model was
evaluated through three ﬁt indexes of conﬁrmatory factor
analysis: the root-mean-square error of approximation
(RMSEA), Bentler comparative ﬁt index (CFI) and Tucker-
Lewis non-normed ﬁt index (TLI). Values of RMSEA <0.06,
and CFI and TLI >0.95 indicate good model ﬁt [21]. Indirect
effects were calculated as the product of two (or more)
regression coefﬁcients, which are equal to the difference
between the total and direct effects. One limitation of this
method is the assumption of normality distribution of
standard errors, therefore we calculated conﬁdence in-
tervals based on 1000 Bootstrap sample replicates.
Path analyses were run in MPlus, version 5.2.Results
Descriptive data on adiposity and cardio metabolic pa-
rameters are presented in Table 1. In general, weight, BMI
and waist circumference mean levels increased with age,
as expected. In comparison to females, blood pressure and
glucose mean levels were higher in males, while insulin
and HOMA-IR were lower, but within normal ranges in
both sexes.
Pearson correlations between adiposity measures in the
three study waves and SBP and HOMA-IR at 21 years are
presented in Table S1, Supplementary material 1.
Direct effects estimated from the path analysis are
shown in Figs. 2 and 3, and total and indirect effects are
presented in Table 2. The association between BMIz in
adolescence (13 and 17 years) and SBP in adulthood wastotally mediated by adiposity tracking (Fig. 2A). The total
effect [b (95% CI)] of BMIz at 13 years on SBP at 21 years
was 0.211 (0.178; 0.244); majority (79%) of it was
explained by the pathway BMIz 13y, BMIz 17y, BMIz 21y to
SBP 21y [0.166 (0.136; 0.195)], while 21% of the effect
occurred through the pathway from BMIz 13y directly to
BMIz 21y, to SBP 21y (Table 2). Total effect of BMIz 13y on
SBP 21y and the effect of BMIz 17y were weaker than the
effect of BMIz 21y on SBP 21y [b Z 0.284 (0.241; 0.327)].
The associations of BMIz with HOMA-IR were stronger
than with SBP (Fig. 2B and Table 2). In general, the path-
ways for HOMA-IR were similar to those found for SBP,
with the effect of BMIz 13 years being mostly mediated by
adult BMIz. However, an additional direct effect between
BMIz 17y and HOMA-IR 21y was found (Fig. 2B). The total
and positive effect of BMIz 17y was 0.179 (0.114; 0.244),
which is the sum of the negative direct effect on the
outcome [b Z 0.240 (0.315; 0.164)] and the positive
indirect effect through BMIz 21y [bZ 0.418 (0.350; 0.487)]
(Table 2). The coefﬁcient of the direct effect of BMIz 17y is
adjusted for BMIz 21 years, and therefore it should be
interpreted as the change on HOMA-IR for one unit in-
crease in the change (BMIz 17y e BMIz 21y); one unit
increase in this variable corresponds to the decrease of one
SD of the BMIz from 17 to 21 years and it is associated with
lower HOMA-IR at 21 years. Regarding central adiposity,
the effect of adolescent WHR was totally mediated by adult
WHR for both SBP and HOMA-IR at 21 years (Fig. 3). The
total effect of WHR 13y on SBP 21y was 0.219 (0.166;
0.271), and the direct effect from WHR 21y was 0.444
(0.410; 0.478). The total effect of WHR 13y on HOMA-IR
Figure 2 Path analysis diagram for the regression of BMIz on SBP (A) and HOMA-IR (B) at 21 years. Data are standardized regression coefﬁcients and
95% conﬁdence intervals. BMIz: body mass index z-score; SBP: systolic blood pressure; HOMA-IR: insulin resistance index; RMSEA: root-mean-
square error of approximation; CFI: comparative ﬁt index; TLI: TuckereLewis non-normed ﬁt index.
Figure 3 Path analysis diagram for the regression of WHR on SBP (A) and HOMA-IR (B) at 21 years. Data are standardized regression coefﬁcients
and 95% conﬁdence intervals. WHR: waist-to-hip ratio; SBP: systolic blood pressure; HOMA-IR: insulin resistance index; RMSEA: root-mean-square
error of approximation; CFI: comparative ﬁt index; TLI: TuckereLewis non-normed ﬁt index.
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WHR 21y was 0.201 (0.148; 0.255).
Discussion
Our study showed that the effect of adolescent total
adiposity on adult blood pressure and insulin resistance
was mostly mediated by adult adiposity, although results
suggest that total adiposity throughout adolescence also
inﬂuences adult insulin resistance, independently of adult
adiposity. Our results also showed that central adiposity
was associated with insulin resistance and blood pressure,
but the effect was completely mediated by adult central
adiposity.
Methodological considerations
More accurate and precise measurements of body
composition are difﬁcult to implement in large
population-based studies, therefore, we used simple
anthropometric indicators of adiposity. Although BMI
cannot distinguish fat mass from fat free mass, it correlates
well with total body mass [22]. However, its use in pae-
diatric age raises additional questions related to the
comparability of this measure across childhood and
adolescence, and therefore we computed the BMI z-scores
according to the WHO growth reference. This is particu-
larly important in our study, since we analysed the effect
of adiposity at different ages during a period of growth,
and this approach minimizes misclassiﬁcation differences
between ages.
Although waist circumference has been frequently used
as an indicator of central adiposity, it is acknowledged
above all as a surrogate of total adiposity that is also
inﬂuenced by abdominal adiposity [23]. Therefore, WCmay be a valuable indicator of central fat, only when cor-
rected for total adiposity. In our study, we used the WHR
as an indicator of central adiposity. This ratio has been
recognized as a measure of body fat distribution, repre-
senting abdominal fat [24], and it has been shown to
correlate well with cardiovascular risk factors [25,26].
The strengths of our study include its population-based
nature and the prospective design. The young age of our
participants also minimizes potential effects of reverse
causation due to complications of disease or medications;
prevalence of self-reported type 1 or type 2 diabetes in our
sample at 21 years was 0.4% and hypertension was 0.1%.
Although our ﬁnal results were computed in the sub-
sample of participants presenting at least two adiposity
measurements, a complete case analysis in 1172 partici-
pants retrieved similar results, suggesting that no major
selection bias exists. Our results were based on path
analysis, which allowed the calculation of total, direct and
indirect effects of adiposity at different ages, on cardio
metabolic outcomes in adulthood. It allowed an easier
interpretation of the life course adiposity effects on adult
outcomes, overcoming the problems of adjusting for adult
attained adiposity [6].
Blood pressure was measured using an automatic de-
vice, rather than with a mercury sphygmomanometer.
However, oscillometric devices such as the OMRON M6
Comfort used in our study have been shown to be valid for
blood pressure assessment [27], even in obese adults [28].
Path analysis models did not include any confounder
variables, and we could not exclude that our estimates
would be attenuated if other factors were taken into ac-
count. However, as we were interested in measuring the
effects of adiposity at different ages, those effects are ex-
pected to be inﬂuenced by similar confounder factors
across age.
Table 2 Total and indirect effects derived from the path analysis model for the association between adiposity (BMIz and WHR) and outcomes
(SBP and HOMA-IR) at 21 years.
Standardized b (95% CI) Standardized b (95% CI)
BMIz SBP 21y HOMA-IR 21y
Total effect of BMIz 13y 0.211 (0.178; 0.244) 0.248 (0.196; 0.299)
Indirect effects
BMIz 13y/ BMIz 17y/ BMIz 21y 0.166 (0.136; 0.195) 0.355 (0.296; 0.414)
BMIz 13y/ BMIz 17y e 0.203 (0.267; 0.140)
BMIz 13y/ BMIz 21y 0.045 (0.026; 0.065) 0.096 (0.055; 0.137)
Total effect of BMIz 17y 0.195 (0.161; 0.229) 0.179 (0.114; 0.244)
Indirect effects
BMIz 17y/ BMIz 21y 0.195 (0.161; 0.229) 0.418 (0.350; 0.487)
WHR SBP 21y HOMA-IR 21y
Total effect of WHR 13y 0.219 (0.166; 0.271) 0.099 (0.063; 0.135)
Indirect effects
WHR 13y/WHR 17y/WHR 21y 0.106 (0.087; 0.125) 0.048 (0.033; 0.063)
WHR 13y/WHR 21y 0.113 (0.068; 0.157) 0.051 (0.026; 0.076)
Total effect of WHR 17y 0.241 (0.204; 0.278) 0.109 (0.077; 0.142)
Indirect effects
WHR 17y/WHR 21y 0.241 (0.204; 0.278) 0.109 (0.077; 0.142)
BMIz: body mass index z-score; WHR: waist-to-hip ratio; SBP: systolic blood pressure; HOMA-IR: insulin resistance index.
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Our results suggest a stronger association of total adiposity
with insulin resistance than with blood pressure, and
support that adolescent total adiposity levels can affect
future insulin resistance independently of adiposity at
early adulthood. This result is not directly comparable with
other studies since no data based on path analysis for
insulin-resistance was previously reported. However,
available evidence also suggests that there is an additional
effect of BMI gains across the life span on adult insulin
resistance, independently of the attained adult BMI [2,3].
Another study, however, found that adolescent BMI was
not associated with risk of diabetes in adulthood, after
adjustment for adult BMI, in contrast to the association
found for coronary heart disease [29].
In our study the effect of BMIz in adolescence (at 13 or
at 17 years) on adult SBP was totally mediated by adult
BMIz. Our results are in accordance with those computed
by path analysis in a sample of Danish men, showing that
despite a direct effect of body size prior to age 11 years was
found, most of the effect of body size during adolescent on
adult SBP was mediated through adult body size [6]. In our
study, effect of BMI at earlier ages was not evaluated since
participants were enrolled only at 13 years of age. Data
from the Northern Finland Birth Cohort 1966 also sug-
gested that the effect of BMI 11e15 years was mediated by
adult BMI [30], however their ﬁndings are not directly
comparable with ours since they used BMI growth veloc-
ities. Comparison with additional studies assessing the
effect of BMI or body weight in childhood or adolescence
on later SBP is limited [5,9,31,32], since other statistical
methods were applied and direct and indirect effects
through adult BMI were not assessed.
The stronger effect of adiposity on insulin resistance is
supported by other studies, which, despite methodological
differences, found results in line with ours. Longitudinalstudies have shown a stronger association of adiposity
with insulin resistance than with blood pressure, both in
paediatric age [33] and in adulthood [34]. The stronger
association of adult adiposity with insulin resistance, and
the additional direct effect from adolescent adiposity, in
contrast to the completely mediated effect by adult
adiposity on blood pressure suggest that the mechanisms
involved for blood pressure may be primarily immediate.
Mechanisms linking obesity to insulin resistance and
blood pressure are complex and not completely under-
stood yet, and therefore further studies are needed to
clarify these differences on the outcomes.
Central adiposity (particularly visceral) has been
described to be more relevant for cardio metabolic out-
comes than total adiposity [17]. In our study, central
adiposity was more strongly associated with SBP, in com-
parison to total adiposity, but not with insulin resistance.
Some studies in adolescents have also shown similar ef-
fects of total and central adiposity on cardio metabolic
outcomes [33,35,36]. Additionally, the WHR in adolescents
may not be as good as in adults to represent body fat
distribution, and particularly to distinguish visceral from
subcutaneous central fat.
In the present study, the results from the life course
path analysis suggest that the effect of adolescent
adiposity on adult blood pressure and insulin resistance is
mostly mediated by adult adiposity. For insulin resistance,
there was also an additional direct effect from total
adiposity at younger ages. Interventions to reduce
adiposity at young ages are expected to result in lower
blood pressure and insulin resistance in young adulthood,
with greater beneﬁts for insulin resistance.Conﬂict of interest
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